Meeting the Challenges of Early Cancer Detection

Are you interested in the latest breakthrough in cancer diagnosis? The Oncuria® bladder cancer test from Nonagen Bioscience utilizes cutting-edge proteomic technology to detect bladder cancer with unparalleled accuracy. By incorporating premium quality reagents from R&D Systems, this multiplex immunoassay boasts an impressive 93% sensitivity and 95% specificity in detecting bladder cancer. Plus, it has been proven to maintain its accuracy across various tumor grades and stages. Don't miss out on this game-changing diagnostic tool - download our literature piece today to learn more!